MEDICAL BIOLOGICAL WARFARE DEFENSE READINES US FORCES DS

File: 120396_sep96_decls7_0003.txt
Page: 0003
Total Pages: 4

Subject: MEDICAL BIOLOGICAL WARFARE DEFENSE READINES US FORCES DS        

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: MEDICAL BIOLOGICAL WARFARE DEFENSE                                                              

Document Number:          1

Folder SEQ  #:        178




                                           UNCLASSIFIED






                                     INFORMATION PAPER


                                                                    5 1
                                                                     DA.'

          SUBJECT: Medical Biological Warfare (BW) Defense Readinec
          U.S. Forces in Operation Desert Shield/Storm (U)

          1. (U) Purpose: To provide information on the medical BV           nse
          readiness for U.S. Forces in operation Desert Shield/Storm

          2.  @ Facts:

              a.  @.From 1988 to the start of.operation Desert Shi
          peace was breaking out. Although stockpiling of BW vaccir          3
          contrary to the world political environment, it had to be           In
          1988 the Army Medical Department (AMEDD) initiated a BW va
          production and stockpiling program using the limited indus
          base capability in CONUS. Contracts for production of ant
          vaccine and botulinum toxoid were established with Michiga
          Department of Public Health in FY88 and FY89, respectively         the
          AMEDD. Other BW vaccines such as Venezuelan Equine Enceph          5
          became part of the stockpile when it transitioned from Mil
          III at the U.S. Army Medical Research and Development Comn

              b.  @Anthrax and botulinum vaccines were in product            'ien
          Operation Desert Shield occurred. only limited stocks had
          accumulated, and production surge in Aug 90 could not meet
          requirements because limited industrial base and strict Fo         I
          Drug Administration requirements for vaccine safety and po
          Although Army owned the BW vaccines at the onset of operat
          Desert Shield, Army immediately made the stockpile availab         the
          services to be used according to CENTCOM priorities.

              c.  @ Success was that the BW Vaccination Program fo
ted on 2 Jan 91 and that over
          anthrax vaccine and             of botulinum toxoid were se        the
          AOR for immunization o service members. More doses were            Lled
          for shipment to the AOR at the conclusion of Desert Storm          -e
          currently being stored in CONUS.

              d. (U) operation Desert Shield/St   orm clearly showed t.      Le
          vaccine production industrial base needs to be increased f,        :h
          BW and endemic disease vaccines. CONUS vaccine production
          capabilities are decreasing because of low profits and higi
          liabilities.


          CIASSIFIED BY: DASG-HCZ
          DECLASSIFY ON: OADR




                                       UNCLASSIFIED
                                              r- T

Document 4 f:/Week-36/BX003203/MEDICAL BIOLOGICAL WARFARE DEFENSE/medical biological warfare defense readines us f:1108961508458
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL BIOLOGICAL WARFARE DEFENSE
Folder Seq # = 178
Subject = MEDICAL BIOLOGICAL WARFARE DEFENSE READINES US F
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996